• Home
  • A-B index
  • Pharmacological Index
  • Drug Classes
  • Active Ingredients
  • Companies
  • News
  • Levetrim Solution
    / Trima


    Active Ingredient
    Levetiracetam 100 mg/ml

    Status in Israel
    RX

    Presentation and Status in Health Basket

    Presentation Basket Yarpa Pharmasoft

    Solution

    300 ml

    partial basket chart 51488 12499

    Related information


    Dosage

    The dosage and the treatment regimen will be determined individually. Keep taking the medicine twice a day, once in the morning and once in the evening, at a set time, according to the doctor’s instruction. Do not exceed the recommended dose. This medicine is not intended for infants and children under 4 years of age. Keep using only the provided syringe, intended for measuring the correct amount of the medicine.
    Note that the units on the provided syringe are in mg.
    If the syringe was mistakenly not provided, consult the pharmacist. After use, separate the parts of the syringe and wash them in lukewarm water and soap. The bottle is closed with a child-proof cap; press and turn in order to open it. Child-proof caps have significantly lowered the number of poisoning cases caused by medicines each year. However, if you find it difficult to open the cap, you can refer to a pharmacist and request that he remove the safety mechanism of the cap and turn it into a regular, easy-to-open cap. The solution can be diluted in a glass of water and swallowed with or without food Even if there is an improvement in your health, do not stop treatment with the medicine without consulting the doctor or pharmacist.
    Discontinuation of the medicine: As with other antiepileptics, discontinuation may increase the seizures. If discontinuation of the medicine is necessary ,the medicine, stop taking the medicine gradually, meaning, a reduction of 500 mg twice a day, at 2 or 4 week intervals. This is to prevent an increase in seizures.                      


    Indications

    Monotherapy in the treatment of partial onset seizures with or without secondary generalisation in patients. From 16 years of age with newly diagnosed epilepsy.
    Adjunctive therapy: In the treatment of partial onset seizures with or without secondary generalisation in adults and children from 4 Years of age with epilepsy. In the treatment of myoclonic seizures in adults and adolescents from 12 years of age with juvenile myoclonic Epilepsy. In the treatment of primary generalised tonic-clonic seizures in adults and adolescents from 12 years of age With idiopathic generalised epilepsy.


    Contra-Indications

    Hypersensitivity to the active substance. Known, rare, hereditary intolerance to fructose.          


    Special Precautions

    Alcohol: drinking of alcohol during the course of treatment with the medicine should be avoided.
    Driving and activities which require alertness: Use of this medicine may impair alertness and cause sleepiness. Therefore, caution is required when driving a car, operating dangerous machinery and when engaging in any activity that requires alertness. This effect occurs primarily at the beginning of treatment and may recur when the Children should be cautioned against riding a bicycle or playing near the road, and the like.
    Please refer to the license holder for further details. 


    Side Effects

    Dizziness (sensation of unsteadiness), convulsions, tremor (involuntary trembling), balance disorders, fatigue, weakness, restlessness. Depression, hostility or aggression, anxiety, insomnia, irritability or nervousness, rash, abdominal pain, indigestion, nausea, vomiting, diarrhea, anorexia (loss of appetite), vertigo (sensation of rotation).
    Please refer to the license holder for further details.        


    Drug interactions

    Other anticonvulsants, probenecid, oral contraceptives.
    Please refer to the license holder for further details.      


    Pregnancy and Lactation

    Pregnancy: It is not recommended for use during pregnancy, unless there is a clear need for it. 
    Lactation: It is not recommended to breastfeed during the course of treatment with this drug.
    Please refer to the license holder for further details.                   


    Overdose

    Signs: drowsiness, agitation, aggression, decreased alertness, inhibition of breathing and coma.
    Please refer to the license holder for further details.


    Important notes

    Storage: Store in a cool place, at a temperature below 25°C. After first opening of the bottle, the medicine can be used for 6 months.


    Manufacturer
    Trima Israel Pharmaceutical Products Maabarot Ltd. Israel
    CLOSE